CN
CytoNavigator™ Experimental

Literature Interpretation

Backed by 300+ Publications. Your Trusted Partner from Start to Finish.

Home Research Literature Literature Interpretation

【烈冰助力Nature正刊】邦耀生物全新一代非病毒定点整合CAR-T技术治疗B-NHL,安全有效!

邦耀生物非病毒定点整合CAR-T技术(QuikinCART®)治疗复发难治性淋巴瘤的临床试验结果表明:87.5%(7/8)的患者获得疾病完全缓解,5例无癌生存已超过1年,首例接受治疗的患者已无癌生存2年! 一代代的科学家和临床学者的坚持探索和仁心仁术,让每位罹患癌症的患者不再畏惧寒冬,这也

2022-09-06
1 2 3 4 5 6 7 8 9 10 11